Medicare Rx Cost Controls Could Drive "Breakthrough" R&D - Rep. Stark
Executive Summary
Medicare prescription drug budgets should be designed to encourage research into "truly new products," Rep. Stark (D-Calif.) suggested in an Aug. 8 memorandum submitted to the HHS drug pricing conference in Washington, D.C.